Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Health Canada

Canada lifts restrictions on gay men's blood donations

Ottawa (AFP) - Canada announced Thursday a lifting of restrictions on blood donations by gay and bisexual men that dates back to the HIV/AIDS crisis of the 1980s and 1990s.

5 Resilient Stocks to Buy for a Market Downturn

5 Resilient Stocks to Buy for a Market Downturn

Yesterday, the broad market indices closed in negative territory on interest-rate-increase concerns. Goldman Sachs has predicted that the S&P might tumble to 3,600 this year if recessionary pressure persists. Non-cyclical stocks usually perform well during economic downturns. So, we believe Cardinal Health (CAH), Brookfield Infrastructure Corp. (BIPC), Smith & Nephew…

Sproutly Forms Joint Venture With Kingston Cannabis, Here Is Why

Sproutly Forms Joint Venture With Kingston Cannabis, Here Is Why

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE:SPR) (FSE: 38G), is expanding its commercial relationship with Kingston Cannabis Inc., a Health Canada Licensed processor.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Health Canada Approves Grapefruit USA's Hourglass Time Release THC+CBD Delivery Cream For Sale

Grapefruit USA, Inc. (OTCQB: GPFT), announced that its notice of new cannabis product (“NNCP”), filed with Health Canada on Jan.

Delic Labs Receives Exemption To Conduct Research On MDMA, LSD And Other Psychedelic Compounds

Delic Labs subsidiary of Delic Holdings Corp (OTCQB:DELCF) (CSE:DELC) (FRA: 6X0), received a Health Canada 56 research exemption that will allow scientists to conduct research and perform tests on a number of compounds outside of psychedelic mushrooms, including MDMA, LSD, DMT, mescaline and 2C-B. Additionally, Delic Labs has received a…

Adastra Submits Medical Sales License Application And Engages IR Labs To Provide Investor Relations Services

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) submitted medical sales license application to Health Canada on April 1, 2022. A medical sales license would permit Adastra to perform the following activities:

Nova Mentis Is Looking To Treat Autism With Psilocybin

Nova Mentis Life Science Corp. (OTCQB:NMLSF) and the private college Toronto Institute of Pharmaceutical Technology have signed a contract for the production of psilocybin capsules. The company will supply the microdose capsules for a Phase 2A fragile X syndrome (FXS) clinical study. FXS, also known as Martin-Bell syndrome, is one…

inkl

Read news from The Economist, FT, and more,
with one subscription

Canadian Cannabis Producers Are Financially Squeezed: Unpaid Marijuana Fees Grow 10X YoY To CA$914K

Canadian Cannabis Producers Are Financially Squeezed: Unpaid Marijuana Fees Grow 10X YoY To CA$914K

Has competition in the Canadian cannabis market finally reached its climax?

Hempsana Teams Up With GAMA To Launch New Cannabis Product Offerings And Brands

Hempsana Teams Up With GAMA To Launch New Cannabis Product Offerings And Brands

Hempsana Holdings Ltd. has entered into a contract manufacturing agreement with GAMA Corp to co-manufacture and distribute new products and brands from the United States to the Canadian and International Markets for both recreational and medicinal use.

Adastra Holdings Approved For Dealer's License For Psilocybin, Psilocin, MDMA, DMT, 5-MeO-DMT & LSD

Adastra Holdings Approved For Dealer's License For Psilocybin, Psilocin, MDMA, DMT, 5-MeO-DMT & LSD

Adastra Holdings Ltd. (OTCPK: XTXXF) (CSE: XTRX) (FRA: D2EP) recently completed the submission of its application for a controlled drugs and substances dealer's license. What Does It Mean?

Health Canada Approves Moderna's COVID-19 Vaccine For Kids Aged 6-11 Years

Health Canada Approves Moderna's COVID-19 Vaccine For Kids Aged 6-11 Years

Health Canada has approved Moderna Inc's (NASDAQ:MRNA) mRNA COVID-19 vaccine, Spikevax, two-dose series of 50 µg per dose to prevent COVID-19 in children aged six to11 years. The announcement follows the recent authorization of the Company's COVID-19 vaccine in the same age group in both Australia and the European Union. "Health Canada was…

Pure Extracts Exports First Shipment Of Cannabis Oil Extracts To German Pharma

Pure Extracts Exports First Shipment Of Cannabis Oil Extracts To German Pharma

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) has successfully exported its first batch of cannabis oil extracts to a German pharmaceutical company under a Health Canada export permit.

RYAH Medtech Secures Health Canada Medical Device License For Its Medical Cannabis Inhaler System

RYAH Medtech Secures Health Canada Medical Device License For Its Medical Cannabis Inhaler System

RYAH Medtech, Inc. subsidiary of RYAH Group, Inc. (CSE:RYAH) has received a Health Canada medical device license for its proprietary internet of things powered medical cannabis inhaler, proprietary cartridges and software application associated with the device.

Tetra Bio-Pharma Gets Health Canada's Approval To Use 100mg Of CBD In Inhaled Cannabidiol Safety Study

Tetra Bio-Pharma Gets Health Canada's Approval To Use 100mg Of CBD In Inhaled Cannabidiol Safety Study

Health Canada approved the amendment of a phase I study by Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB: TBPMF) (FRA: JAM1) conducted in collaboration with Dr.

Get all your
news in one place.

100’s of premium titles.
One news app.

Hempsana Holdings Receives Health Canada's Approval To Sell Medical Cannabis Directly To Patients Across Canada

Hempsana Holdings Ltd. has received its medical sales license from Health Canada which provides the company the ability to sell cannabis products directly to medical patients across Canada.

HYTN Innovations Receives Health Canada's Approval To Sell Cannabis

HYTN Innovations Inc.’s (CSE:HYTN) subsidiary HYTN Cannabis Inc., has awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers.

Novavax's COVID-19 Vaccine Scores Canadian Approval

Health Canada approves Novavax Inc's (NASDAQ: NVAX) Nuvaxovid COVID-19 Vaccine in individuals 18 years of age and older.

The Canadian Press

Health Canada authorizes the use of Nuvaxovid COVID-19 vaccine

Health Canada has authorized the use of a fifth COVID-19 vaccine to add to its arsenal and perhaps lead to an uptick in vaccinations among people who remain hesitant.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Canadian Press

Unvaccinated truckers delivering vaccines, COVID devices exempt from border rules

OTTAWA — Unvaccinated truckers bringing COVID-19 vaccines and medical devices into Canada to combat the pandemic are exempt from testing and quarantine requirements at the border, a government order says.

The Canadian Press

Advocates thrilled as court orders Health Canada to reassess glyphosate decision

OTTAWA — A popular weed killer is back under review after the Federal Court of Appeal ruled that Health Canada didn't follow its own rules for regulating pesticides and herbicides.

Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants

Health Canada has allowed a phase 2 clinical trial of psilocybin in patients currently undergoing treatment with traditional antidepressants.

The Canadian Press

A Paxlovid primer: what to know about the new oral antiviral treatment for COVID-19

OTTAWA — Health Canada authorized the first at-home, oral treatment for COVID-19 Monday. But what is Paxlovid, how does it work and who can get it? Here are some answers.

Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed

Health Canada approved Pfizer Inc's (NYSE: PFE) oral antiviral treatment for mild to moderate cases of COVID-19 in adults.

The Canadian Press

Top News Advisory for Friday, Jan. 17

Here are the latest Top News stories from The Canadian Press. All times are Eastern unless otherwise stated. Coverage plans are included when available. Entries are subject to change as news develops.

The Canadian Press

Health Canada approves Pfizer antiviral but supply issues expected

OTTAWA — Health Canada approved Pfizer's antiviral treatment for COVID-19 Monday which could help cut pressure on the health-care system by preventing high-risk patients from ending up in the hospital.

People

Stéphane Bancel

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Wikimedia Commons

Vertex Pharmaceuticals Incorporated

Cardinal Health Inc

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

245,500 stories

British Columbia

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play